Diabetes Drug Could Protect Against Dangerous Infection
Federation of American Societies for Experimental Biology (FASEB)Researchers from Wake Forest School of Medicine in North Carolina have demonstrated that a common diabetes drug inhibits the spread of Clostridioides difficile, or C. diff—a potentially life-threatening infection commonly acquired during hospital stays. The team will present their work virtually at the American Physiological Society’s (APS) annual meeting at Experimental Biology 2021.